Today’s AI Top Pick: TMDX

7/9/2026 · Highly Shorted High Growth Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Highly Shorted High Growth Deep RotationTMDXBUY NOW8.6 / 107/9/2026

TransMedics (TMDX) is the cleanest confluence in this pool of screen-passers: strong fundamentals AND multi-timeframe tape confirmation without being extended. Bullish_prob is 1.0 with near_term_bullish also at 1.0, and all four timeframes point higher in the mid/long horizon — 1h fc_mid +24.2% / fc_long +59.2%, 4h fc_mid +61.2% / fc_long +135.3%, 1d fc_mid +68.6% / fc_long +57.1%, and even the beaten-up 1wk turns positive on mid (+30.1%) and long (+28.0%). This is genuine agreement, not a single-bar outlier. Crucially, the entry is not chased. Position-in-21bar-range is 32.3% on the daily and just 8.8% on the weekly, with a -51.5% weekly drawdown from the 21-bar high — this is a deeply-rotated name coming off a base, not an extension. Fundamentals do the heavy lifting from here: PE 16.17, fwd PE 21.45, ROE 45.22, profit margin 27.04%, sales YoY +30.24%, EPS next year +70.83%, analyst recom 1.64 with 65% target upside. Fundamental score 6.75, one of the highest in the pool that also has confirming tape (PGY's 8.0 is undercut by weekly fc_short -24.9% and fc_mid -19%). Headline risk is contained: the recent news is Evercore ISI maintaining Outperform (target trimmed to $90) and a Motley Fool 10-year piece — trims, not a guidance cut, legal action, dilution, or short-seller hit. Compare to alternatives with real landmines: NRDS got a SeekingAlpha downgrade citing 'worsening economics,' CRK carries a Goldman sell rating with a $10 target, QXO is now under 'regulatory scrutiny' per today's headline, and CELH is trading heavier than the tape. Why today: the daily and 4h forecasts have already flipped decisively positive while price is still in the lower third of its 21-bar range — waiting risks paying up as the fc_short +52.7% on the daily begins to unfold. This is the textbook 'deep rotation, tape confirming' setup this lens is built to catch.

Entry zone

$68.50 – $71.50 (scale in around current $70.42, add on any dip toward the 4h dd zone)

Stop loss

$62.90 (below the -10.6% daily 21-bar drawdown level; ~11% risk)

First target

$84 – $87 (reclaim of upper daily range, ~20% move, aligns with fc_short/fc_mid daily projections)

Longer target

$105 – $115 (fills weekly fc_mid/fc_long +28-30%, matches ~65% analyst target upside)

Risks

23.02% short float — a squeeze cuts both ways; a fresh negative catalyst can accelerate downside
Weekly still shows -51.5% drawdown and a -3.89% fc_short — near-term weekly momentum has not fully turned
Evercore just trimmed target to $90 (from higher); further analyst cuts would pressure sentiment
Debt/Equity 1.75 is elevated for a med-tech; rising rate scares can compress the multiple
Fwd PE 21.45 vs trailing PE 16.17 means Street already prices in growth — a single soft OCS/transplant volume print resets the story

Honorable mentions

KVYOBullish_prob 1.0, near_term 1.0, all timeframes positive (1d fc_mid +48.5%, 1wk fc_mid +116.6%), and a real positive catalyst (AI Marketing Agent launch, Lightspeed integration). Held back only because it's at 81% of daily range — better as BUY_PULLBACK than chase.

PSIXBest pure value screen (PE 7.82, ROE 75.67, PEG 1.52) with 1d fc_mid +75.6% and fc_long +74.5% off a deep -60% weekly drawdown at 0% of weekly range. Downgraded to #3 because weekly forecast is still deeply negative (fc_mid -49.9%) — trend hasn't turned on the highest timeframe yet.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	TMDX	BUY NOW	8.6	All 4 timeframes bullish, mid-range entry, ROE 45 / margins 27%, only headline is a mild analyst trim.
2	KVYO	BUY PULLBACK	7.8	Full-conviction tape (1wk fc_mid +116.6%) and AI catalysts, but 81% of daily range says wait for a dip.
3	PSIX	BUY NOW	7.5	Deep-value turnaround (PE 7.8, PEG 1.5) with daily fc_short +57.9% off the range low, weekly still ugly.
4	UPST	BUY NOW	7.2	1wk fc_long +162.8% and fc_mid +58%, near_term 1.0, high short float 32.75% = squeeze fuel.
5	MNDY	BUY PULLBACK	7.0	Weekly fc_mid +204% and Q1 beat, but 1h/1d position mixed and near_term only 0.4.
6	PGY	WAIT	6.4	Best fundamental_score (8) but weekly fc_short -24.9% and fc_mid -19% undercut the tape thesis.
7	BRZE	BUY PULLBACK	6.3	JPM raised PT, Goldman positive, 1wk fc_long +97.6% — decent but 1h at 0% of range shows near-term weakness.
8	CELH	BUY PULLBACK	6.2	1wk fc_mid +51.6%, near_term 1.0, but weak trading action per today's headline.
9	VSTM	WAIT	6.0	1wk fc_long +85%, RBC Outperform, but at 100% of daily range and 1wk fc_short -23.4% — chase risk.
10	FOUR	BUY PULLBACK	5.9	Fwd PE 7.03 and 1wk fc_long +51.7%, but 1h/4h forecasts weak and 1h fc_long -17.5%.
11	KLAR	WAIT	5.6	JPM/UBS positive but limited tape history (perfYear null), fund_score just 1.0.
12	ALKT	BUY PULLBACK	5.5	Jana activist stake is a catalyst; 1wk fc_long +48% but 1h at 0% of range.
13	NRDS	WAIT	5.3	Cheap (fwd PE 8.26) but SeekingAlpha downgrade citing 'worsening economics' is a real landmine.
14	CRK	WAIT	5.1	PE 6.58, ROE 25 but Goldman Sell + PT $10 caps upside; weekly fc_short still -1.76%.
15	FIP	BUY PULLBACK	5.0	Jones Trading Buy PT $8.75, 1d fc_short +22.9% but 1wk still deeply negative.
16	PDYN	WAIT	4.9	Preliminary Q2 sales +480% and USAF contract — great catalysts but 1wk fc_long -42.5% cancels the tape.
17	SOFI	WAIT	4.7	Bullish_prob only 0.4, 1wk fc_mid -30.7%, recom 2.8 — screen passes but signals don't confirm.
18	MUX	WAIT	4.5	Fund_score 8 (PE 15.97, PEG 0.07) but bullish_prob 0 and expected_return only +1.97%.
19	DVLT	AVOID	4.4	Sub-$0.40 penny with 1wk fc all zeros — speculative meme headline flow only.
20	BTDR	WAIT	4.3	AI data center lease is a positive but 4h fc_long -81.9% and 1d drawdown -29.3% is deteriorating.
21	ASST	AVOID	4.2	PS 176.7, profit margin -12,110%, essentially a bitcoin treasury proxy — no fundamental floor.
22	QXO	AVOID	4.0	Today's headline flags regulatory scrutiny — thesis materially undercut regardless of forecasts.
23	ABAT	WAIT	3.9	DOE grant reinstatement is positive but bullish_prob 0 and 1wk fc_long -24.7%.
24	ASPI	WAIT	3.8	Merger/helium deals are catalysts but 1wk fc_mid/long both -25% and 1d dd -29.5%.
25	KULR	WAIT	3.6	Near_term_bullish 0, 1h fc_short -2.48%, still bleeding across shorter timeframes.
26	TOYO	AVOID	3.3	Fund_score 8 but recent $50M dilutive raise, 1d fc_short -7%, expected_return -32.7%.
27	SAIL	AVOID	3.2	Insider resales headline + bullish_prob null; no conviction signal.
28	BKV	AVOID	3.0	Bullish_prob 0, expected_return -3.2%, and SeekingAlpha dilution warning.
29	STIM	AVOID	2.9	Debt/Equity 6.43, profit margin -24.5%, thin data on tape — micro-cap with balance-sheet risk.
30	DFDV	AVOID	2.5	ROE -2398%, D/E 12.5, target cut by Cantor — broken balance sheet regardless of screen match.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord